FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

François Meyer

Research Profile

Disorders

Geographic Areas

Quebec

Chemicals & Drugs

Concepts & Ideas

Procedures

Objects

Dietary Supplements

Activities & Behaviors

Questionnaires

Co-author Network

Publications

TOP 3
Alice Nourissat; Bernard Têtu; Abdenour Nabid; Isabelle Bairati; François Brochet; André Fortin; Michel Gélinas; François Meyer
Factors associated with weight loss during radiotherapy in patients with stage I or II head and neck cancer.
François Meyer; Geoffrey Liu; Pierre Douville; Elodie Samson; Wei Xu; Araba Adjei; Isabelle Bairati
Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients.
Alice Nourissat; Isabelle Bairati; Elodie Samson; André Fortin; Michel Gélinas; Abdenour Nabid; François Brochet; Bernard Têtu; François Meyer
Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of François Meyer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Alice Nourissat; Bernard Têtu; Abdenour Nabid; Isabelle Bairati; François Brochet; André Fortin; Michel Gélinas; François Meyer
Factors associated with weight loss during radiotherapy in patients with stage I or II head and neck cancer.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012;20(3):591-9.
2011: François Meyer; Geoffrey Liu; Pierre Douville; Elodie Samson; Wei Xu; Araba Adjei; Isabelle Bairati
Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients.
International journal of cancer. Journal international du cancer 2011;128(7):1741-6.
2010: Alice Nourissat; Isabelle Bairati; Elodie Samson; André Fortin; Michel Gélinas; Abdenour Nabid; François Brochet; Bernard Têtu; François Meyer
Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer.
Cancer 2010;116(9):2275-83.
2009: François Meyer; André Fortin; Michel Gélinas; Abdenour Nabid; François Brochet; Bernard Têtu; Isabelle Bairati
Health-related quality of life as a survival predictor for patients with localized head and neck cancer treated with radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(18):2970-6.
2008: Dominique Trudel; Yves Fradet; François Meyer; François Harel; Bernard Têtu
Membrane-type-1 matrix metalloproteinase, matrix metalloproteinase 2, and tissue inhibitor of matrix proteinase 2 in prostate cancer: identification of patients with poor prognosis by immunohistochemistry.
Human pathology 2008;39(5):731-9.
2008: François Meyer; Isabelle Bairati; André Fortin; Michel Gélinas; Abdenour Nabid; François Brochet; Bernard Têtu
Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: a randomized trial among head and neck cancer patients.
International journal of cancer. Journal international du cancer 2008;122(7):1679-83.
2008: Melanie K Sackett; Isabelle Bairati; François Meyer; Edith Jobin; Sébastien Lussier; André Fortin; Michel Gélinas; Abdenour Nabid; François Brochet; Bernard Têtu
Prognostic significance of cyclooxygenase-2 overexpression in glottic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(1):67-73.
2007: François Meyer; Isabelle Bairati; Edith Jobin; Michel Gélinas; André Fortin; Abdenour Nabid; Bernard Têtu
Acute adverse effects of radiation therapy and local recurrence in relation to dietary and plasma beta carotene and alpha tocopherol in head and neck cancer patients.
Nutrition and cancer 2007;59(1):29-35.
2006: Isabelle Bairati; François Meyer; Edith Jobin; Michel Gélinas; André Fortin; Abdenour Nabid; François Brochet; Bernard Têtu
Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients.
International journal of cancer. Journal international du cancer 2006;119(9):2221-4.
2006: François Meyer; Bernard Têtu; Isabelle Bairati; Louis Lacombe; Yves Fradet
Prostatic intraepithelial neoplasia in TURP specimens and subsequent prostate cancer.
The Canadian journal of urology 2006;13(5):3255-60.
2006: Lise Fillion; Marie de Serres; Richard Lapointe-Goupil; Isabelle Bairati; Pierre Gagnon; Michèle Deschamps; Josée Savard; François Meyer; Lynda Bélanger; Georges Demers
Implementing the role of patient-navigator nurse at a university hospital centre.
Canadian oncology nursing journal = Revue canadienne de nursing oncologique 2006;16(1):11-7, 5-10.
2005: François Meyer; Pilar Galan; Pierre Douville; Isabelle Bairati; Pastelle Kegle; Sandrine Bertrais; Sébastien Czernichow; Serge Hercberg
A prospective study of the insulin-like growth factor axis in relation with prostate cancer in the SU.VI.MAX trial.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(9):2269-72.
2005: Isabelle Bairati; François Meyer; Michel Gélinas; André Fortin; Abdenour Nabid; François Brochet; Jean-Philippe Mercier; Bernard Têtu; François Harel; Belkacem Abdous; Eric Vigneault; Sylvie Vass; Pierre del Vecchio; Jean Roy
Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5805-13.
2005: François Meyer; Pilar Galan; Pierre Douville; Isabelle Bairati; Pastelle Kegle; Sandrine Bertrais; Carla Estaquio; Serge Hercberg
Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial.
International journal of cancer. Journal international du cancer 2005;116(2):182-6.
2005: Brant A Inman; François Harel; Jean-François Audet; François Meyer; Pierre Douville; Yves Fradet; Louis Lacombe
Insulin-like growth factor binding protein 2: an androgen-dependent predictor of prostate cancer survival.
European urology 2005;47(5):695-702.
2005: Isabelle Bairati; François Meyer; Michel Gélinas; André Fortin; Abdenour Nabid; François Brochet; Jean-Philippe Mercier; Bernard Têtu; François Harel; Benoît Mâsse; Eric Vigneault; Sylvie Vass; Pierre del Vecchio; Jean Roy
A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.
Journal of the National Cancer Institute 2005;97(7):481-8.
2004: Linda Perron; Isabelle Bairati; François Harel; François Meyer
Antihypertensive drug use and the risk of prostate cancer (Canada).
Cancer causes & control : CCC 2004;15(6):535-41.
2003: Dominique Trudel; Yves Fradet; François Meyer; François Harel; Bernard Têtu
Significance of MMP-2 expression in prostate cancer: an immunohistochemical study.
Cancer research 2003;63(23):8511-5.
2003: Linda Perron; Isabelle Bairati; Lynne Moore; François Meyer
Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer.
International journal of cancer. Journal international du cancer 2003;106(3):409-15.
2002: Linda Perron; Lynne Moore; Isabelle Bairati; Paul-Marie Bernard; François Meyer
PSA screening and prostate cancer mortality.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2002;166(5):586-91.
2001: Louis Lacombe; A Maillette; François Meyer; C Veilleux; Lynne Moore; Yves Fradet
Expression of p21 predicts PSA failure in locally advanced prostate cancer treated by prostatectomy.
International journal of cancer. Journal international du cancer 2001;95(3):135-9.
2000: Maryse Simoneau; Hélène LaRue; Tahar O Aboulkassim; François Meyer; Lynne Moore; Yves Fradet
Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest.
Oncogene 2000;19(54):6317-23.
2000: Isabelle Bairati; R Larouche; François Meyer; Lynne Moore; Yves Fradet
Lifetime occupational physical activity and incidental prostate cancer (Canada).
Cancer causes & control : CCC 2000;11(8):759-64.
2000: C Pfister; Hélène LaRue; Lynne Moore; Louis Lacombe; C Veilleux; B Tetu; François Meyer; Yves Fradet
Tumorigenic pathways in low-stage bladder cancer based on p53, MDM2 and p21 phenotypes.
International journal of cancer. Journal international du cancer 2000;89(1):100-4.
2000: Hélène LaRue; P Allard; Maryse Simoneau; C Normand; C Pfister; Lynne Moore; François Meyer; Bernard Têtu; Yves Fradet
P53 point mutations in initial superficial bladder cancer occur only in tumors from current or recent cigarette smokers.
Carcinogenesis 2000;21(1):101-6.
1999: C Pfister; Lynne Moore; P Allard; Hélène LaRue; Louis Lacombe; Bernard Têtu; François Meyer; Yves Fradet
Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(12):4079-84.
1999: C Pfister; Louis Lacombe; M C Vezina; Lynne Moore; Hélène LaRue; Bernard Têtu; François Meyer; Yves Fradet
Prognostic value of the proliferative index determined by Ki-67 immunostaining in superficial bladder tumors.
Human pathology 1999;30(11):1350-5.
1999: François Meyer; Isabelle Bairati; Ramak Shadmani; Yves Fradet; Lynne Moore
Dietary fat and prostate cancer survival.
Cancer causes & control : CCC 1999;10(4):245-51.
1999: Yves Fradet; François Meyer; Isabelle Bairati; Ramak Shadmani; L Moore
Dietary fat and prostate cancer progression and survival.
European urology 1999;35(5-6):388-91.
1998: François Meyer; Y Fradet
Prostate cancer: 4. Screening.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1998;159(8):968-72.
1998: François Meyer; Lynne Moore; Isabelle Bairati; Yves Fradet
Quebec prostate cancer mortality dropped in 1996.
Cancer prevention & control : CPC = Prévention & contrôle en cancérologie : PCC 1998;2(4):163-6.
1997: François Meyer; Isabelle Bairati; Yves Fradet; L Moore
Dietary energy and nutrients in relation to preclinical prostate cancer.
Nutrition and cancer 1997;29(2):120-6.
1996: François Meyer; Isabelle Bairati; Gilles R Dagenais
Lower ischemic heart disease incidence and mortality among vitamin supplement users.
The Canadian journal of cardiology 1996;12(10):930-4.
1993: Isabelle Bairati; L Roy; François Meyer
Measurement errors in standard visual analysis of coronary angiograms: consequences on clinical trials.
The Canadian journal of cardiology 1993;9(3):225-30.
1992: Isabelle Bairati; L Roy; François Meyer
Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty.
Circulation 1992;85(3):950-6.
1992: Isabelle Bairati; L Roy; François Meyer
Effects of a fish oil supplement on blood pressure and serum lipids in patients treated for coronary artery disease.
The Canadian journal of cardiology 1992;8(1):41-6.
1990: François Meyer; J Moisan; D Marcoux; C Bouchard
Dietary and physical determinants of menarche.
Epidemiology (Cambridge, Mass.) 1990;1(5):377-81.